The 14 genes do not completely distinguish between Biopsy‐based CD diagnosis and Anti‐TG2‐based CD diagnosis, but as long as no treatment recommendations are based on these subgroups, a classification based on two classes (Active CD and Not CD) is sufficient. This evidence concerns the gene TGM2 and Cowden disease.